Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders

Movement Disorders : Official Journal of the Movement Disorder Society
Jong-Hoon KimYong Sik Kim

Abstract

The metric properties of the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) were examined in 182 subjects treated with antipsychotics. Inter-rater reliability, test-retest reliability, and concurrent validity with other rating scales for EPS were high. Four factors were identified and the optimal diagnostic cut-off scores were obtained. These results suggest that the DIEPSS is a reliable and valid multidimensional rating scale.

References

May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Dec 1, 1994·Archives of General Psychiatry·P Sachdev, J Kruk
Apr 1, 1993·Acta Psychiatrica Scandinavica·J GerlachD E Casey
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·P Martínez-MartínF Bermejo
Dec 1, 1995·Psychiatry and Clinical Neurosciences·Toshiya Inada, G Yagi
Mar 1, 2000·The Journal of Clinical Psychiatry·C A MelfiR L Robinson
Jun 27, 2000·Australian and New Zealand Journal of Medicine·A S Granger, H C Hanger
May 10, 2001·The International Journal of Neuropsychopharmacology·Anton J. M. LoonenArnold E. S. Sijben
Nov 20, 2002·Comprehensive Psychiatry·Jong-Hoon KimYong Sik Kim

Citations

Apr 15, 2009·Current Treatment Options in Neurology·Frandy Susatia, Hubert H Fernandez
Mar 17, 2004·Advanced Drug Delivery Reviews·Samir Mitragotri
Mar 17, 2004·Advanced Drug Delivery Reviews·Samir Mitragotri, Joseph Kost
Mar 17, 2004·Advanced Drug Delivery Reviews·Anne-Rose DenetVéronique Préat
Mar 17, 2004·Advanced Drug Delivery Reviews·Gregor Cevc
Dec 31, 2003·International Journal of Pharmaceutics·O PillaiR Panchagnula
Aug 1, 2013·Ultrasonics·Donghee ParkSeunghun Lee
Sep 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amit Joshi, Jaideep Raje
Apr 25, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amnon C SintovGalit Levin
May 28, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·A M de GraaffJoke A Bouwstra
Sep 5, 2003·International Journal of Pharmaceutics·Babu M Medi, Jagdish Singh
Oct 16, 2003·International Journal of Pharmaceutics·Gai Ling LiJoke A Bouwstra
Sep 16, 2003·International Journal of Pharmaceutics·Victor M MeidanBozena B Michniak
Aug 14, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·B W Barry
Jul 27, 2001·Current Opinion in Chemical Biology·O PillaiR Panchagnula
Jun 30, 2010·The International Journal of Neuroscience·Jong-Hoon Kim, Hee-Jung Byun
Apr 7, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Da Young YunHee-Yeon Jung
Sep 19, 2007·Journal of Clinical Pharmacy and Therapeutics·Jong-Hoon Kim, Hee-Jung Byun
Dec 1, 2010·Journal of Clinical Pharmacy and Therapeutics·Jong-Hoon KimJinyoung Lee
Dec 14, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jong-Hoon KimYong Sik Kim
Nov 29, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jong-Hoon KimYong Sik Kim
Mar 1, 2012·Psychiatry Research·Jong-Hoon KimZang-Hee Cho
Apr 21, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Sung-Wan KimYoung-Myo Jae
Aug 12, 2009·The Australian and New Zealand Journal of Psychiatry·Jae Seung ChangYong Sik Kim
Jul 11, 2015·Journal of Psychopharmacology·Astrid M van StrienRob J van Marum
Oct 21, 2015·The Australian and New Zealand Journal of Psychiatry·Norman Jay StomskiAmanda Meyer
Mar 31, 2017·Journal of Physical Therapy Science·Yoko TsujiFumio Hirao
Nov 13, 2004·Journal of Clinical Psychopharmacology·Jong-Hoon KimYong Sik Kim
Oct 12, 2010·The Australian and New Zealand Journal of Psychiatry·Jong-Hoon KimJinyoung Lee
Mar 14, 2018·Clinical Neuropharmacology·Yen-Feng Lee
Jun 29, 2017·The Cochrane Database of Systematic Reviews·Javier Ortiz-OrendainClive E Adams
Jul 4, 2018·Psychiatry Investigation·Sook-Hyun LeeSeunghyong Ryu
Feb 11, 2009·Human Psychopharmacology·Jong-Hoon Kim, Hee-Jung Byun
Jan 16, 2010·Journal of Clinical Psychopharmacology·Wilma KnolRob J van Marum
Sep 18, 2020·The American Journal of Hospice & Palliative Care·Hiroto IshikiSatoru Iwase
Jun 11, 2018·International Journal of Bipolar Disorders·Joseph R CalabreseHiroaki Kawasaki
Jul 15, 2020·International Journal of Psychiatry in Medicine·Deirdre Caffrey, Gillian L Sowden
Jul 9, 2020·Journal of Clinical Psychopharmacology·Stanley N CaroffE Cabrina Campbell
Sep 19, 2019·Nordic Journal of Psychiatry·Bernhard WeidleToshiya Inada

Related Concepts

Lenticulostriate Disorders
Dyskinesia, Medication-Induced
Neurologic Examination
Schizophrenia
Antipsychotic Effect
Intraobserver Variation
Pseudoakathisia
Ramsay Hunt Paralysis Syndrome

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here